Cytotopic (Cyto-) IL-15 as a New Immunotherapy for Prostate Cancer: Recombinant Production in Escherichia coli and Purification

Interleukin-15 (IL-15) is a cytokine previously suggested as a potential immunotherapy for cancer treatment. IL-15 can effectively reduce tumor growth in many preclinical tumor models including prostate cancer. This is due to its ability to expand and activate immune cells, such as CD8+ T cells and...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Ana M. Esteves, Efthymia Papaevangelou, Dorota Smolarek, Prokar Dasgupta, Christine Galustian
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-10-01
coleção:	Frontiers in Molecular Biosciences
Assuntos:	IL-15 Escherichia coli protein purification cytotopic modification prostate cancer immunotherapy
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fmolb.2021.755764/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!